Mehr zum Buch
During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer`s disease, attention is also being focused on issues relating to cognitive impairment associated with "normal" aging. This book is useful as a source of information for making informed decisions regarding the relative utility and attributes of the various neural targets that have been studied to date.
Buchkauf
Milestones in Drug Therapy: Cognitive Enhancing Drugs, Jerry J. Buccafusco, Michael J. Parnham, Jacques Bruinvels
- Sprache
- Erscheinungsdatum
- 2003
- Einband
- (Hardcover),
- Buchzustand
- Gebraucht - Sehr gut
- Preis
- € 76,39
Keiner hat bisher bewertet.
- Titel
- Milestones in Drug Therapy: Cognitive Enhancing Drugs
- Sprache
- Englisch
- Autor*innen
- Jerry J. Buccafusco, Michael J. Parnham, Jacques Bruinvels
- Verlag
- Birkhäuser
- Erscheinungsdatum
- 2003
- Einband
- Hardcover
- Seitenzahl
- 203
- ISBN10
- 3764369825
- ISBN13
- 9783764369828
- Reihe
- Schlagwörter
- Medizin & Gesundheit, Wissenschaft, Medizin, Gesammelte Werke, Psychiatrie, Neurowissenschaft, Neurologie, Pharmakologie, Toxikologie, Pharmakotherapie
- Beschreibung
- During the past decade research into the pharmacology of cognition, particularly regarding learning and memory, has supported the concept that many potential neural targets exist for the development of cognitive-enhancing drugs. Whereas the main impetus for this research has been the ever growing population of individuals with dementing disorders such as Alzheimer`s disease, attention is also being focused on issues relating to cognitive impairment associated with "normal" aging. This book is useful as a source of information for making informed decisions regarding the relative utility and attributes of the various neural targets that have been studied to date.